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Human decidual cells are known to produce l,25-(OH)2Dg at the end of pregnancy, the present study evaluates this capacity, and the part played 
by stromal decidual cells, in early pregnancy. Cells were obtained from nine human decidua by aspiration or curettage during early pregnancy (7-10 
weeks), separated on Ficoll-Paque and plastic adherence, and incubated for 1 h with 25-(OH)D1. Incubation medium and cells were extracted and 
chromatographed on two successive HPLC systems. The cells examined were of both physiological and pathological (ectopic pregnancy) origin. 
Endometrial cells obtained in four non-pregnant situations (myomas) were also studied to determine whether the l,25-(OH)zD, synthesis by the 
uterus is associated with the appearance of decidual cells. Results show that human decidual cells from early pregnancy convert 25(OH)D, (2.5 
nM or 2.5 PM) into a metabolite with the physicochemical characteristics of synthetic 1,25-(OH),D,. This ability is shared by cells isolated during 
early pregnancy, whether physiological or ectopic (tubal pregnancy). Non-adherent cells, which include mainly stromal decidual cells, are less able 
to produce 1,25-(OH),D, than are the adherent cells, suggesting that macrophages, granulocytes or as yet unidentified cell types are required for 
the l,25-(OH)2D, production by decidual tissue during early human pregnancy. In addition, one out of four experiments with non-pregnant 
endometrial cells could produce 1,25-(OH),D, suggesting that, although not the rule in the non-pregnant state, in vitro production of l,25-(OH)2Dg 
by uterine cells can be found in the absence of decidual cells. 
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1. INTRODUCTION 
The kidney has long been considered to be the exclu- 
sive site at which 1,25dihydroxyvitamin D, (1,25- 
(OH),D,), the hormonal active form of vitamin D,, is 
synthesized [14]. This concept is based on experimental 
results showing that 1,25-(OH)*D3 is no longer formed 
after bilateral nephrectomy [l]. However, this is clearly 
not the case during pregnancy, as rat maternal blood 
contains 1,25-(OH),D, even after experimental bilateral 
nephrectomy [5,6], and as foeto-placental tissues from 
both animals and humans synthesize 1,25-(OH),D, in 
vitro [7-131. 
Studies on the ability of the human uterine cells to 
synthesize 1,25-(OH),D, have so far been mostly limited 
to the late pregnancy period [g-13], and/or have in- 
volved incubations with whole tissue homogenates 
[8,9,12,13]. The location and characterization of the 
cells responsible for the 1,25-(OH),D, synthesis in the 
feto-placental unit at this time of pregnancy remains a 
fertile field for debate [8-131. To date, an in vitro 1,25- 
(OH),D, production has been observed during incuba- 
tions of placenta homogenate or mitochondria 
[9,12,13]. But this 1,25-(OH)*D3 production appears to 
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require high substrate concentrations (0.1-100 ,uM of 
25-(OH)D,), and may be dependent upon an enzyme 
system different from that described in kidney mito- 
chondria [13]. In contrast, cultured decidual tissue or 
cell produce 1,25-(OH),D, when incubated with 25- 
(OH)D3 concentrations as low as 0.6-6 nM [8,10,11], 
with a K, of 88 nM [14], similar to that reported for 
cultured kidney cells [14], and for human pulmonary 
macrophages from patients with sarcoidosis, a classical 
extrarenal site of 1,25-(OH),D, production [15]. Thus, 
cells of decidual origin may be a source, even if not a 
major one [16], of maternal circulating 1,25-(OH),D3, 
the concentration of which is elevated during late preg- 
nancy [17-191. 
This study evaluates the ability of decidual cells ob- 
tained during early pregnancy to synthesize 1,25- 
(OH),D, in vitro. The cells examined were of both phys- 
iological and pathological (ectopic pregnancy) origin, 
since decidualization of the endometrium occurs as well 
in case of uterine or ectopic egg implantation. Several 
studies clearly indicate the heterogeneity of the cell pop- 
ulations present in early gestational human decidua [2CL 
221. Two cell populations were studied after isolation by 
Ficoll-Paque and a further fractionation by plastic ad- 
herence, a technique which has been shown to separate 
populations containing mainly stromal decidual cells 
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from populations containing a number of other cell 
types including macrophages [20]. Endometrial cells ob- 
tained in non-pregnant pathological situations were 
also studied to determine whether the 1,25-(OH),D, 
synthesis by the uterus is associated with the appearance 
of decidual cells. 
2. MATERIALS AND METHODS 
2.1. Tissues 
Decidual tissue was collected from nine pregnant uteri at presuma- 
bly 7 to 10 weeks of gestational age after mild aspiration and curettage 
for elective termination of physiological pregnancy (samples l-8), and 
by curettage during surgical treatment of ectopic tubal pregnancy 
(sample 9). Special care was taken to avoid contamination by trophob- 
lastic cells. 
Four samples of non-pregnant endometrial tissues were obtained 
from uteri after surgical hysterectomy for single (sample 10) or multi- 
ple myomas (samples 11-13) and with (samples 12,13) or without 
(samples 10,ll) moderate inflammatory infiltrates. The endometrial 
samples were taken from apparently unaffected parts of the uterus 
from non-cyclic (sample lo), or cyclic (first part: sample 11; second 
part, samples 12 and 13) women aged 3649 years. 
Endometrial and decidual tissues were immediately transferred into 
sterile ice-cold minimal essential medium (MEM, Gibco, France). 
2.2. Disaggregation of cells 
The method used was that described by Parhar et al. [20]. Briefly, 
tissues were washed in ice cold MEM, freed from blood clots, mucus, 
and any chorionic villi, washed again to minimize contamination by 
trophoblastic ells, and minced finely with a scalpel. Minced tissue (1 
g) was digested in 10 ml calcium and magnesium-free phosphate- 
buffered saline containing 0.1 mg/ml collagenase type IA (Sigma, 
France) for 60 min at 37°C. Cells were collected by centrifugation (5 
min at 900 x g) and the undigested tissues were incubated with collage- 
nase for two further 30 min periods. The cells were washed with 
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, France) con- 
taining 10% fetal calf serum (FCS, Seromed, France). In some exper- 
iments, RPM11640 culture medium (Gibco, France), was used instead 
of DMEM. The suspension was then filtered through sterile cheese- 
cloth (60 pm nylon mesh NY,,) and the cells separated by centrifuga- 
tion for 20 min on a Ficoll-Paque density gradient at 3500 rpm (density 
1.078, Pharmacia). The cells at the interface (Ficoll-medium) were 
removed, washed, counted, and resuspended in culture medium 
RPM11640 or DMEM + 10% FCS at lo6 cells/ml. The viability of the 
recovered fresh cells, as assessed by Trypan blue exclusion, was 94%. 
Cells (lO?ml) were then incubated overnight in glass Lab-Tek cham- 
ber slides (Miles laboratory, Naperville, IL, USA) at 37°C under 95% 
air, 5% COZ. Adherent and, in some experiments, non-adherent cells 
isolated from the decidual or endometrial tissues were kept after the 
overnight culture for further analysis. 
2.3. In vitro metabolism of 2S(OH)D3 
The capacity of adherent and non-adherent cells to metabolize 
25(OH)D, in vitro was assessed by incubating lo6 viable cells for 60 
min (at 37”C, 95% air, 5% CO*) in glass Lab-Tek chamber slides 
containing 2 ml serum-free DMEM or RPM11640. 
10 ~1 of ethanol were then added which contained 50 nCi [26,27-‘HI- 
25(OH)D, (20 Ci/mmol, Radiochemical Centre, Amersham, UK; final 
concentration 2.5 x 10e9 M). After 60 min, cells were scraped free and 
the medium and cells were transferred to glass tubes. Two ml methanol 
plus 2 ml chloroform were added to each sample. After 24 h at 4°C 
the chloroform phase was removed, dried under N2, and the residue 
redissolved in chromatographic solvent. Before chromatography, 80 
ng unlabeled synthetic 1,25-(OH),DS (Hoffman-La Roche, Inc., Nut- 
ley, NJ) were added to extracts from cells as a marker of the 1,25- 
(OH),D, elution position detectable at 254 nm. To quantify 1,25- 
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(OH),D3 production, samples were chromatographed on a direct 
phase HPLC system (Beckman, Berkeley, CA, USA) using an Ultra- 
sphere Si column (5pm, 4.6 x 250mm, Altex, Berkeley, CA, USA) and 
a 92:8 n-hexanelisopropanol solvent (flow rate 1.6 ml/min). The meta- 
bolites corn&rating with the simultaneously injected synthetic 1,25- 
(OH),D, were rechromatographed on the same HPLC system using 
a 95:5 methylene-chloride/isopropanol solvent (flow rate 1 mYmin) as 
previously described [23]. The rate of conversion of [‘H]25(OH)D, into 
[3H]1,25-(OH),D, was determined by calculating the percentage of 
total radioactivity with an appropriate elution profile after the two 
successive separations. Results are expressed as fmoY106 cells per 1 h, 
assuming that the specific activity of the product was the same as that 
of the substrate. Thus, conversion of 1% substrate corresponds to the 
production of 25 fmol [3H]1,25-(OH),D,. 
2.4. Binding of putative 1,25-(OH),D, to I.25-(OH),D, receptors 
Other decidual cell incubations were made in the presence of 1 pug 
unlabeled 25(OH)D, (Roussel-Uclaf Laboratories, Paris, France; final 
concentration 1 x 10e6 M) instead of 2.5 x 10e9 M [‘H]25(OH)D,. The 
putative 1,25-(OH),D, produced during these incubations was puri- 
fied as above with one exception, cell and medium extracts were 
cochromatographed on HPLC with 2 nCi synthetic [3H]1,25-(OH),D, 
as a radioactive marker of the 1,25-(OH),D3 elution position. The 
putative purified 1,25-(OH),D, was tested for its ability to compete 
with synthetic [3H]1,25-(OH),D, for binding to the 1,25-(OH),D, re- 
ceptors in chick intestinal cytosol [24]. The metabolite produced was 
quantified from its absorbance at 254 nm. 
3. RESULTS 
Human decidual and endometrial cells converted 2.5 
nM [26,27] [3H]25(OH)D3 into polar radioactive deriva- 
tives when incubated for 1 h in serum-free RPM11640 
or DMEM (Figs. 1 and 2). 
We have been interested in the metabolite that coe- 
luted with synthetic 1,25-(OH),D, in the two sequential 
HPLC chromatographic systems. Further analysis of 
this putative 1,25-(OH),D, was made after incubation 
of the cells with larger amounts of 25-(OH)D3 (1 PM). 
This confirmed the identification of the metabolite as 
1,25-(OH),D,. Decidual cells produced a metabolite de- 
tected by UV absorbance at 254 nm which coeluted with 
synthetic [3H]1 ,25-(OH),D3 in the two sequential HPLC 
chromatographic systems. This metabolite also had the 
same capacity as synthetic 1,25-(OH&D, to compete 
with [3H]1,25-(OH),D3 for binding to the chick intesti- 
nal cytosol receptor (Fig. 3, Table I). The only known 
vitamin D metabolite with these characteristics i  1,25- 
(OH),D3 [25-271. 
It was necessary to chromatograph samples on two 
successive systems in order to isolate 1,25-(OH),D, 
from another 25-(OH)D, derivative which was pro- 
duced by all tested cell populations. This latter deriva- 
tive could be (5E)-19-nor-lo-oxo-25(OH)D, [26,27]. It 
was present in the 26-29 ml elution fractions containing 
the synthetic 1,25-(OH),D, after chromatography in the 
first HPLC system, but was detected in the 9-10 ml 
fraction, before 1 ,25-(OH)2D3, in the second HPLC sys- 
tem (Figs. 1 and 2). Moreover, incubations of decidual 
cells with 2.5 PM 25-(OH)D3 showed that this derivative 
did not absorb UV light at 254 nm, and did not bind to 
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Fig. I. Typical high-pressure liquid chromatography elution profiles 
of the radioactivity extracted from human decidual cells incubated 
with 2.5 nM [‘H]25(OH)D,, and the absorbance at 254 nm of 80 ng 
unlabeled synthetic 1,25(OH)rDp added to extracts before chromatog- 
raphy. (A) First chromatography using a 92:8 n-hexanelisopropanol 
solvent, the elution position of (52)-19-nor-lo-oxo-25(OH)D, in this 
system is 22-24 ml, that of (5E)-19-nor-lo-oxo-25(OH)D, is2629 ml; 
(B) chromatography using a 95:5 methylenechloride/isopropanol s l- 
vent of the 1,25(OH),D, region isolated from (A), the elution position 
of (5Z)-19-nor-lo-oxo-25(OH)D, in this second HPLC system is 67 
ml, that of (5E)-19-nor-lo-oxo-25(OH)D, is 9-10 ml. Hatched bars: 
radioactivity coeluted with synthetic 1,25(OH)rD3. Note that most of 
the radiocativity eluting in the 1,25(OH)rD, region in the first HPLC 
system also coelutes with 1,25(OH)rD, in the second HPLC system. 
1,25-(OH)zD3 receptors in chick intestinal cytosol (sam- 
ples 6 and 7, data not shown). 
The incubation medium influenced the ability of the 
cells to convert [26,27-3H]250HD3 into [3H]1 ,25- 
(OH),D3. This ability was not detectable in the 6 uterine 
cell populations tested in RPM1 (below 1.5 fmol/106 
cells/h). It was detectable in 10 of the 13 uterine cell 
populations tested in DMEM (Table I). 
Adherent human decidual cells from all eight samples 
obtained during physiological early pregnancy con- 
verted [3H]25(OH)D3 into [3H]1 ,25-(OH)*D, (1.75-l 1 
fmoY106 cells/h), as did the adherent decidual cells ob- 
tained from the patient with an ectopic pregnancy 
(Table I). In contrast, only one of the four samples of 
endometrial adherent cells from non-pregnant patients 
with myomas converted [3H]25(OH)D3 into [3H]1 ,25- 
(OH),D, (Table I). The three other endometrial samples 
converted [3H]25(OH)D3 only into the (5E)-19-nor-lo- 
oxo-25(0H)D,-like derivative (Fig. 2). 
Non-adherent decidual cells had a 3- to 1 l-fold lower 
capacity to convert [3H]25-(OH)D3 into [3H]1 ,25- 
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Fig. 2. Typical high-pressure liquid chromatography elution profiles 
of the radioactivity extracted from human non-pregnant endometrial 
cells incubated with 2.5 nM [‘H]25(OH)D,, and the absorbance at 254 
nm of 80 ng unlabeled synthetic 1,25(OH),D, added to extracts before 
chromatography. (A) First chromatography using a 923 n-hexanel 
isopropanol solvent, the elution position of (5Z)-19-nor-lo-oxo- 
25(OH)D, in this system is 22-24 ml, that of (SE)-19-nor-lo-oxo- 
25(OH)D, is 2629 ml; (B) chromatography using a 95:5 methylene- 
chloride/isopropanol solvent of the 1,25(OH)*D, region isolated from 
(A), the elution position of (Sk?)-1Pnor-lo-oxo-25(OH)D, in this sec- 
ond HPLC system is 67 ml, that of (5E)-19-nor-lo-oxo-25(OH)D, is
9-10 ml. Hatched bars: radioactivity coeluted with synthetic 
1,25(OH),D,. Note that most of the radiocativity eluting in the 
1,25(OH),D, region in the first HPLC system does not coelute with 
1,25(OH),D, but migrates to the (5E)-19-nor-IO-oxo-25(OH)D, re- 
gion in the second HPLC system. 
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Fig. 3. Characterization of 1,25(OH),D, produced by human decidual 
cells incubated with 2.5 PM unlabeled 25(OH)D,. The metabolite 
coeluting with synthetic [‘H]1,25-(OH),D, on the two successive 
HPLC systems (see Fig. 1) was isolated. Its ability to compete with the 
binding of [3H]1,2.5(OH)2D, to its chick intestinal receptor (closed 
symbols) was compared with that of known amounts of synthetic 
1,25(OH),D, (open symbols). 
(OH),D, than the adherent cells from the same uterine 
samples (Fig. 4). 
4. DISCUSSION 
Cells obtained from human decidua by aspiration or 
curettage during early pregnancy (7-10 weeks) and sep- 
arated on Ficoll-Paque convert [3H]25(OH)D, into a 
metabolite with the physicochemical characteristics of 
synthetic 1,25-(OH),D,: the synthetic and biosynthetic 
1,25-(OH),D3 coeluted in the two HPLC chromato- 
graphic systems used, had similar UV absorbance at 
254 nm, and competed identically with [3H]1,25- 
(OH),D, for binding to chick intestinal cytosol receptor. 
Following the reports of Weisman et al. [5], Gray et 
al. [6], and Tanaka et al. [7], kidney is no longer consid- 
ered to be the sole site of 25-(OH)D,-1 a-hydroxylation 
during pregnancy. Several studies have reported that 
the term human feto-placental unit can produce 1,25- 
(OH),D, [8-131. But the location and characterization 
of the cells responsible for this synthesis in the feto- 
placental unit is not clear. Human trophoblastic tissue 
homogenates produce 1,25-(OH),D, in vitro [9,12,13], 
but not under all experimental conditions [8], and only 
when high substrate concentrations are used, 0.1-100 
,uM. Moreover, the K, of this production is higher, 570 
nM [12], than that reported for 1,25-(OH),D3 produc- 
tion by kidney cells, 125 nM [15], and trophoblastic 
tissue may produce 1,25-(OH)2D, in vitro by a mecha- 
nism different from the classical one involving the cyto- 
chrome P450 mixed function oxidase [13]. 
As for human decidual tissue, term decidua basalis 
incubated in vitro with high substrate (100 PM) concen- 
trations cannot produce 1,25-(OH),D, in vitro [9]. But 
term decidua parietalis express this capacity when incu- 
bated with nM 25-(OH)D, concentrations [8,10,1 l] with 
a Km, 88 nM [ll], similar to that reported for kidney 
cells [ 151. In the present study, decidual cells expressed 
the capacity to form 1,25-(OH),D, as early as the 7- 
10th week of pregnancy and this ability was similar to 
that reported for human decidual cells at the end of 
pregnancy. Indeed, 2-l 1 fmoles / lo6 cells / h [3H]1 ,25- 
(OH),D, was produced by incubation of early preg- 
nancy decidual cells with 2.5 nM [3H]25-(OH)D3, while 
full-term decidual cells produce 33-l 68 fmoY106 cells/l 6 
h with similar concentrations of [3H]25-(OH)D3, 6 nM 
[lo]. Moreover, incubations of early pregnancy decidual 
cells with 2.5 ,uM 25-(OH)D, produced 4.5-5 pmol/106 
cells/h 1,25-(OH)*D3, and the V_ for such production 
by late pregnancy decidual cells is 3 + 0.4 pmol/106 
cells/h [ 111. The 1,25-(OH),D, production by both early 
and late pregnancy decidual cells appears to be lower 
than that obtained with cultured chick kidney cells, 
about 50 pmol/106cells/h [15], but it is similar to that 
reported for cultured human pulmonary macrophages 
from patients with sarcoidosis, 0.4-2.5 pmol/106 cells/h 
[16]. The results of the present study confirm the ability 
of cells from human decidual tissue to produce 1,25- 
(OH),D, in vitro, when incubated with 2.5 or 2500 nM 
25-(OH)D, concentrations, and show that this ability is 
shared by cells isolated during early pregnancy, whether 
physiological or even ectopic (tubal pregnancy). 
The control of extrarenal 1,25-(OH),D, synthesis ap- 
pear to be different from that of the renal synthesis of 
Table I 
1,25-(OH),D, production by adherent human decidual cells and non- 
pregnant endometrial cells (fmol/106 cells/h) 
Experiments 1,25-(OH),D, produced during incubation with 
2.5 nM [‘H]25-(OH)D, 2.5 PM 25-(OH)D,b 
Human decidua 
1* 1.75 (1.5- 2.0) 
2* 11.00 (7.0-15.0) 
3 2.00 
4 2.02 
5 5.31 
6 2.62 
7 _ 4500 
8 _ 5000 
9’ 5.50 
Non-pregnant uturus 
10 < 1.50 
11 < 1.50 
12 < 1.50 
13’ 7.00 (6.4 7.7) 
a 1,25-(OH),D, production was estimated from the amount of radioac- 
tivity coeluting with synthetic 1,25-(OH&D, on the 2 HPLC systems, 
It was assumed that [‘H]1,25-(OH),D, produced and the [‘H]25- 
(OH)D, substrate had identical specific activities. 
b 1,25-(OH),D, production was quantified by direct UV absorbance 
at 254 nm, and, measured more precisely by the radioreceptor assay 
shown in Fig. 3. 
’ Ectopic tubal pregnancy. 
*Mean value, and range of duplicate incubations. 
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l Adherent cells 
Non-adherent cells 
Fig. 4. Comparison of the capacity of adherent and non-adherent 
decidual cells to convert [Hj25(OH)D, into [3H]1,25(OH)2D,. Cells 
were obtained from three samples from decidual tissues and separated 
by Ficoll-Paque and plastic adherence as described in section 2.1 x lo6 
cells were incubated with 2.5 nM [‘H]25(OH)D, in serum-free DMEM 
medium, and the amount of [‘H]1,25(OH),D, produced was deter- 
mined as described in section 2. Bars represent the mean of individual 
values for each cell population. 
this metabolite [30-331. Delvin et al. showed that neither 
inorganic phosphate salts (WI mM), nor parathyroid 
hormone had any acute effect on 1 ,25-(OH)2D, produc- 
tion by human term decidual cells [ll]. Hollis et al. 
suggested that the enzyme system responsible for this 
production in decidual cells may be, like for the tro- 
phobiastic portion of the human placenta, different 
from that present in the kidney mitochondria [ 131. Such 
a hypothesis has not been tested yet, but above men- 
tioned data of kinetic studies suggest similarities be- 
tween 1,25-(OH),D, productions by human decidual 
cells and kidney mitochondria [8,10,11], which are not 
found with term human placenta [12,13]. In our experi- 
mental conditions, 1,25-(OH),D, production by human 
adherent decidual cells depends on the incubation me- 
dium used. It was detectable in DMEM but not in 
RPM1 1640 medium. As these media differ mainly in 
their inorganic phosphate salt concentrations, respec- 
tively 0.9 mM for DMEM and 5 mM for RPMI1640, 
phosphorus may regulate 1,25-(OH),D, production by 
human decidual cells, at least during early pregnancy. 
Parallel studies of adherent and non-adherent cells 
isolated from the same early gestational decidual tissues 
provide further indications of the characteristics of the 
cells responsible for 1,25-(OH),D,, production. It is 
known that the cell populations isolated from the de- 
cidua depend on the isolation method used, bone-mar- 
row derived cells are preferentially selected by enzyme 
digestion whereas mechanical disaggregation isolates 
cell populations in proportions which are more repre- 
sentative of those found in the intact tissue [22]. Cell 
populations from early gestational human decidua can 
be fractionated by Ficoll-Paque and further fraction- 
ated by plastic adherence into adherent and non-adher- 
ent cells. Non-adherent cells contain mainly stromal 
decidual cells (96%), almost no macrophages and a 
small number of other cell types, including 1% tropho- 
blastic cells. Adherent cells include, besides a similarly 
small amount of trophoblastic cells (l%), more macro- 
phages (25%) and granulocytes (9%) and less stromal 
type decidual cells (about 60%) [20]. Using this cell frac- 
tionation technique, we found that non-adherent cells 
were less able to produce 1,25-(OH),D, than were the 
adherent cells. This suggests that macrophages, gran- 
ulocytes or as yet unidentified cell types are required for 
the 1,25-(OH),D, production by decidual tissue during 
early human pregnancy. These cell types may be the 
source of 1,25-(OH),D, or they may secrete local factors 
which stimulate the 1,25-(OH),D, production by 
stromal decidual cells. 
Finally, the studies on human endometrial cells from 
non-pregnant pathological uteri suggest that, unlike 
during pregnancy, 1,25-(OH),D, production by human 
uterine endometrial cells is not the rule in the non- 
pregnant state. But, as one of the four samples tested 
did produce 1,25-(OH)*D3, perhaps some uterine pa- 
thologies can lead to the production of 1 ,25-(OH),D3 by 
the uterus. Hartwell et al. [34] recently reported that 
women with endometriosis have significantly higher 
serum 1,25-(OH),D, concentrations than healthy 
women. Our in vitro findings suggest hat such elevated 
1,25-(OH),D, concentrations may be due to the local 
uterine synthesis of this metabolite and that uterine cells 
other than stromal decidual cell can express a 25- 
(OH)D,- 1 a-hydroxylase activity. 
In conclusion, human decidual cell populations iso- 
lated by Ficoll-Paque and plastic adherence from early 
physiological and pathological (ectopic) pregnancy 
uteri can synthesize 1,25-(OH),D,. Although not the 
rule, endometrial cells isolated from cases of non-preg- 
nant uterine pathologies are also able to produce 1,25- 
(OH),D,. Cell populations other than stromal decidual 
cells are required for this synthesis. 
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